This correlation was also evident in triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer characterized by the absence of Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2 (Fig. 6c). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.